Atrial Tachycardia is a cardiac arrhythmia characterized by a rapid heartbeat originating in the atria, the upper chambers of the heart. Unlike normal heartbeats that are regulated by the sinoatrial (SA) node, individuals with atrial tachycardia experience an abnormal firing of electrical signals from within the atria, leading to a faster heart rate than the typical range of 60 to 100 beats per minute. This condition can be episodic or sustained, causing symptoms such as palpitations, shortness of breath, and dizziness. Diagnosis often involves the use of electrocardiograms (ECGs) to detect the rapid heart rhythm. Management strategies may include medications to control the heart rate, radiofrequency ablation to eliminate the abnormal electrical pathways, or, in severe cases, implantation of a pacemaker. A comprehensive understanding of the underlying causes, risk factors, and available treatment options is crucial for healthcare professionals to effectively manage and improve the quality of life for individuals with atrial tachycardia.
Title : Surgical fetal stem cells implantation in heart failure patients long term results at 14 years
Federico Benetti, Benetti Foundation, Argentina
Title : Exploring new biomarkers of cardiomyopathy
Shuping Zhong, University of Southern California, United States
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Cancer and cardiovascular diseases: Common pathogenesis mechanisms and risk factors
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : Lipoprotein (a): The hidden cardiovascular risk
Syed Raza, Awali Hospital, Bahrain